Dynamic Technology Lab’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Dynamic Technology Lab’s Portfolio EIGR Stock Details EIGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-639	Closed	-$18K	–	1512
2023 Q1	$18K	Buy	+639	New	+$29.7K	﹤0.01%	1020
2022 Q4	–	Sell	-358	Closed	-$81K	–	1614
2022 Q3	$81K	Sell	358 -349	-49%	-$85.8K	0.01%	1039
2022 Q2	$134K	Buy	+707	New	+$143K	0.02%	965

Other funds holding EIGR

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Dynamic Technology Lab's EIGR Position: Q2 2023 in Review

Dynamic Technology Lab sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q2 2023, closing a stake of 639 shares — an estimated $18K sold.

Dynamic Technology Lab first reported a position in EIGR in Q2 2022 and held it in 3 quarters. The position peaked at $134K in Q2 2022. 66 funds tracked by Wall St. Rank hold EIGR as of Q2 2023.

Dynamic Technology Lab reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
Dynamic Technology Lab sold 639 Eiger BioPharmaceuticals, Inc. shares in Q2 2023, an estimated $18K.
Dynamic Technology Lab first reported a position in Eiger BioPharmaceuticals, Inc. in Q2 2022 and held it in 3 quarters.
Dynamic Technology Lab's Eiger BioPharmaceuticals, Inc. position peaked at $134K in Q2 2022.
66 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q2 2023.

Based on Dynamic Technology Lab's 13F filing for Q2 2023, filed 14 Aug 2023.